Three sites in Europe – One strong group

Analytical Services for the life science industry

The Kymos Group is an analytical CRO with three European laboratories devoted to providing bioanalytical and CMC solutions throughout the entire product life cycle: from early research and development to manufacturing and comercialization. We are GLP- and GMP-certified, have been successfully inspected by the EMA and the FDA and are experts in analytical and quality control work with small molecules, biologics and oligonucleotides. We provide services to clients worldwide in the pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetic and nutraceutical industries.

Please accept marketing-cookies to watch this video.

PRE-CLINICAL & CLINICAL BIOANALYSIS

CMC ANALYSIS & QUALITY CONTROL

Testimonials

“We are currently developing multiple new biosimilar projects and consider Kymos one of the best CROs in Europe for drug release and testing.”

Yong Suk Yang, Global QC Operation Team Manager, CELLTRION, INC

“We were positively impressed when Kymos reacted to our needs by investing in their stability capabilities, and now, two years down the line, with projects in full-swing, I can safely say that we made the right choice. In Kymos we have found a reliable, committed, trustworthy and professional partner.”

Dr. Dino Mangion, Head of Malta Operations, MEDICHEM/COMBINO PHARMA Ltd

“Back in 2017 there weren’t many analytical CROs able to carry out Franz cell assays and Kymos’ pioneering work was pivotal for the registration of our product.”

Dr. Marius Strunk, Senior Pharmaceutical Development Manager, HELM AG

“Kymos offered superior historical expertise by being exposed to so many different clients, pharmacological compounds, and therapeutic areas. They addressed and anticipated very diverse problems.”

Dr. Pablo Avilés, PHARMAMAR S.A.

“I have had a long and fruitful experience with Kymos and have a huge interest in their participation owing to their reliability.”

Jaime Algorta, Medical Affairs Director , EXELTIS HEALTHCARE S.L.U.

“Prolytic is our analytical partner throughout the entire drug development process. Such a long and complex process requires a laboratory you can trust. Professional yet flexible, Prolytic accompanies us through the preclinical and clinical phases.”

“Establishing robust miRNA methods for valuable results is tricky. The team at Prolytic have been a key collaboration partner. With their 30 years of experience in bioanalytics and broad know-how in different techniques, study types, and substance groups, we were able to quickly develop a reproducible and reliable analysis method for miRNAs.”

Dr. Meike Saul, Research Group Leader, Technische Universität Darmstadt

PROBLEMS WITH ANY ANALYTICAL METHOD? – ASK OUR EXPERTS

Ask us

Latest News

Get in touch


    EU Sites

    Barcelona
    Spain

    Frankfurt
    Germany

    Ancona
    Italy

    EU Offices

    Paris
    France

    Basel
    Switzerland

    Milano
    Italy